<!-- COPYRIGHT NOTICE This file is part of the "Universal Biomedical Skills" project. Copyright c 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu All Rights Reserved. This code is proprietary and confidential. Unauthorized copying of this file, via any medium is strictly prohibited. Provenance:
Install with the open skills CLI (global, non-interactive — available in every Claude Code session):
npx skills add FreedomIntelligence/OpenClaw-Medical-Skills --skill "bio-research-tools-biomarker-signature-studio" -g -a claude-code -yOr manually — clone and copy the skill directory (SKILL.md + companion files):
git clone --depth 1 https://github.com/FreedomIntelligence/OpenClaw-Medical-Skills /tmp/OpenClaw-Medical-Skills && cp -r /tmp/OpenClaw-Medical-Skills/skills/bio-research-tools-biomarker-signature-studio ~/.claude/skills/bio-research-tools-biomarker-signature-studioThis skill is a directory: SKILL.md is the entry point; the files below ship with it.
<!--
# COPYRIGHT NOTICE
# This file is part of the "Universal Biomedical Skills" project.
# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>
# All Rights Reserved.
#
# This code is proprietary and confidential.
# Unauthorized copying of this file, via any medium is strictly prohibited.
#
# Provenance: Authenticated by MD BABU MIA
-->
---
name: bio-research-tools-biomarker-signature-studio
description: Multi-omic biomarker discovery studio that ingests expression + metadata, performs QC, multi-strategy feature selection, nested CV model training, survival analysis hooks, and SHAP-based interpretation. Use to design translational biomarker panels with documented evidence.
tool_type: python
primary_tool: scikit-learn
depends_on:
- machine-learning/biomarker-discovery
- machine-learning/model-validation
- machine-learning/omics-classifiers
- differential-expression/de-results
- workflow-management/biomarker-pipeline
measurable_outcome: Run biomarker_signature_studio.py end-to-end on provided data within 20 minutes and produce metrics + feature rankings JSON artifacts.
allowed-tools:
- read_file
- run_shell_command
---
# Biomarker Signature Studio
Design validated biomarker panels that are explainable, stable, and ready for translational follow-up. This skill stitches together the existing biomarker pipeline tooling, adds configurable feature-selection ensembles, a small survival-analysis hook, and artifact export so downstream lab teams can review QC outputs.
## What This Skill Does
1. **QC + Harmonization:** Align expression matrices (samples x features) with metadata, check label balance, and compute summary stats.
2. **Feature Selection Ensemble:** Supports Boruta, elastic-net stability, mutual-information top-K, and mRMR with optional intersection voting.
3. **Model Factory:** Trains multiple estimators (Logistic L1, RandomForest, XGBoost if present) under nested CV, picks champion by AUC.
4. **Explainability + Export:** Produces SHAP tables/plots when packages are available, exports feature rankings and model weights.
5. **Survival Hook:** If metadata contains `time_to_event` and `event` the skill computes concordance for selected features via Cox model.
All logic lives in `scripts/biomarker_signature_studio.py`.
## Inputs
- Expression matrix (`--expression`): CSV/TSV genes x samples or samples x genes (auto-detected by metadata match).
- Metadata (`--metadata`): Must contain `--label-column`. Optional `--id-column` (default `sample_id`), `time_to_event`, `event`.
- Optional gene list for filtering (`--feature-list`).
- Output directory (`--output-dir`), created if missing.
## Quick CLI Usage
```bash
python Skills/Research_Tools/Biomarker_Signature_Studio/scripts/biomarker_signature_studio.py \
--expression data/expression.csv \
--metadata data/metadata.csv \
--label-column phenotype \
--selectors boruta,lasso,mrmr \
--models rf,logit \
--output-dir outputs/biomarkers_run1
```
Key flags:
| Flag | Description |
|------|-------------|
| `--selectors` | Comma list of selection strategies (`boruta`, `lasso`, `mrmr`, `mi_topk`). |
| `--models` | Models to evaluate (`logit`, `rf`, `xgb`). |
| `--k-features` | Target number of features for `mrmr`/`mi_topk`. |
| `--survival` | Enable Cox evaluation when survival columns exist. |
| `--random-state` | Reproducibility. |
| `--nested-folds` | Outer CV folds (default 5). |
## Workflow
1. Load + align inputs, infer orientation, impute missing values.
2. Standardize features (fit on train set only).
3. Run requested selectors; create intersection + union candidate lists.
4. For each selector output run nested CV training across requested models.
5. Export champion metrics (`metrics.json`), feature table (`selected_features.csv`), SHAP summary (`shap_summary.csv` when available), and survival stats (`survival.json`).
## QC Expectations
- Class count ratio ≤3:1; warnings logged otherwise.
- Selected features between 5 and 250 unless user overrides.
- Nested CV AUC ≥0.70 or flagged in report.
- SHAP overlap with selected features ≥60% (reported).
## Related Assets
- `examples/configs/biomarker_studio_template.yaml` (scaffold for teams)
- `scripts/biomarker_signature_studio.py` (entry point)
- Existing biomarker workflow skill for orchestrated runs.
Use this skill whenever you need a ready-to-review biomarker dossier (data QC, model metrics, explainability artifacts) before moving to validation cohorts or lab assays.
<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->
Search arXiv papers by keyword, author, category, or ID.
Gateway to 400+ bioinformatics skills from bioSkills and ClawBio. Covers genomics, transcriptomics, single-cell, variant calling, pharmacogenomics, metagenomics, structural biology, and more. Fetches domain-specific reference material on demand.
> Pharmaceutical research assistant for drug discovery workflows. Search bioactive compounds on ChEMBL, calculate drug-likeness (Lipinski Ro5, QED, TPSA, synthetic accessibility), look up drug-drug interactions via OpenFDA, interpret ADMET profiles, and assist with lead optimization. Use for medicinal chemistry questions, molecule property analysis, clinical pharmacology, and open-science drug research.